Dr Sarah C Clarke MA, MD, FRCP, FESC, FACC is a Consultant Cardiologist and the Clinical Director for Strategic Development at Royal Papworth Hospital, Cambridge. She has a specialist interest in interventional cardiology. She has a track record in management, service innovation and implementation. She has a regional and national profile.
Dr Clarke trained in Cambridge, UK and at the Massachusetts General Hospital, Boston, USA. She was appointed Consultant Interventional Cardiologist at Royal Papworth Hospital in Cambridge in 2002. She was Clinical Director for Cardiac Services (2006-2012) leading the development and introduction of the PPCI service across the East of England. She has been Clinical Director for Strategic Development since 2012 and was Cardiology Lead for the design and development of New Royal Papworth Hospital opening 2019. She was Cardiology Lead for the Cambridge and Peterborough STP from 2015-2019 developing evidence based clinical pathways across the system and addressing cross-cutting themes such as outpatients and out-of-hours oncall.
In 2017, she was appointed Joint National Lead for Cardiology for the GIRFT, ‘Getting It Right First Time’ programme helping to improve the quality of care within the NHS by reducing unwarranted variations, bringing efficiencies and improving patient outcomes across over 130 Trusts in the UK. The National Report for Cardiology is due publication early next year.
Dr Clarke has been involved in the work of the British Cardiovascular Society since 2000. As Vice President for Education and Research, she became the first female Officer and Trustee of the Society in 2011. She was elected the first female Immediate Past President in 2015 and took the Society through an ambitious modernisation programme to provide a better service for members and deliver key initiatives in quality improvement, education, research and data science.
Dr Clarke was elected Councillor and Trustee to the Board of the Royal College of Physicians (London) in 2018 and in 2019 was elected Clinical Vice President responsible for the Care Quality Improvement Division.
Dr Clarke is Trustee to the Board of the British Heart Foundation (BHF) and a member of the Board of the European Society of Cardiology (ESC) in 2019, chairing the Media Committee. She is European Representative on the Assembly of International Governors of the American College of Cardiology (ACC) and Co-chair of the International Centres of Excellence Programme (ACC). Dr Clarke is Editor for Education in Heart, the international peer-reviewed journal and International Editor of the European Heart Journal.
In 2018 Dr Clarke was awarded a grant to attend the Women Transforming Leadership Programme at the Säid Business School in Oxford and in the same year was awarded the International Service Award by the President of the American College of Cardiology for her outstanding contribution to enhancing cardiovascular care and education throughout the world.
One of her significant personal achievements was running her first Marathon in London earlier this year raising more than £12K for the British Heart Foundation.
Specialist Clinical Interests
General cardiology (including chest pain, murmurs and valve disease, palpitation/arrhythmia, dizziness/blackout, shortness of breath, heart failure, hypertension) and Interventional cardiology (angiography, coronary angioplasty, coronary stenting, rotablation for calcified narrowing’s, chronic total occlusions).
Evaluation new technologies, devices.
IVUS, pressure wire studies.
Collaborates with colleagues performing interventional coronary trials
To view Dr Clarke's clinical outcomes, please click on this link. This will take you to the British Cardiovascular Intervention Society website which is not part of the Papworth Hospital website.
Dr Clarke studied medicine at Girton College, University of Cambridge where she obtained a BA in 1987 and MB BChir in 1989.
Following junior hospital posts in the region her specialist training was undertaken at Addenbrooke’s and Papworth Hospitals.
She was awarded a Fellowship in Interventional Cardiology at the Massachusetts General Hospital and Harvard Medical School, University of Harvard, Boston, USA in 2001. Dr Clarke gained extensive experience in all aspects of interventional cardiology and vascular intervention.
Dr Clarke was awarded her research doctorate in medicine (MD) in 2004, by the University of Cambridge, UK.
She was elected a Fellow Royal College of Physicians (FRCP), London in 2006, Fellow of the European Society of Cardiology (FESC) and a Fellow of the American College Cardiology (FACC) in 2010.
Registered with the General Medical Council (registration number: 3331406)
Fellow Royal College Physicians (London) - FRCP
Fellow European Society of Cardiology- FESC
Fellow American College Cardiology- FACC
Member British Cardiovascular Society (President from 2015 to 2018)
Member British Cardiovascular Intervention Society
Clarke SC, Schofield PM, Grace AA, Metcalfe JC, Kirschenlohr HL. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis Circulation 2001; 103(11): 1497-502
Hoole SP, Heck PM, Sharples L, Khan S, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP, Cardiac Remote ISchaemic Preconditioning in Coronary Stenting (CRISP stent) Study: a prospective randomised controlled study. Circulation 2009
Centre of Excellence, Papworth Hospital, Papworth Everard, Cambridge, England. Circulation: European Perspectives April 20, 2010